CAVHANZA FDA approval date

The FDA approved CAVHANZA on 29 May 2026.

FDA approval date
29 May 2026

Drug identity has not yet been verified against registry records

Also recorded as NILOTINIB

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2026-05-29DayCAVHANZAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA217379", "applicant_as_listed_by_fda": "CYCLE", "brand_names": ["CAVHANZA"], "active_ingredients": ["NILOTINIB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20260529", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026